Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Rare Blood Disorders Platform (ENROL)

NCT06250595 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.

NCT NCT06250595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06250595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Rare Blood Disorders Platform (ENROL)
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2022
Completion date
July 31, 2037
Enrollment
37,090 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, anemia, sickle cell, bleeding disorder, blood cancer, bone marrow failure, iron metabolism disorders, leukemia, lymphoid neoplasm, myeloma, myeloma, malignant, red cell membrane and enzyme abnormalities, thalassemia